Crystal structures of active Src kinase domain complexes

被引:70
作者
Breitenlechner, CB
Kairies, NA
Honold, K
Scheiblich, S
Koll, H
Greiter, E
Koch, S
Schäfer, W
Huber, R
Engh, RA [1 ]
机构
[1] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
[2] Roche Diagnost GMBH, Pharma Res, D-82372 Penzberg, Germany
关键词
crystal structure; drug design; cell signalling; Src; protein kinase;
D O I
10.1016/j.jmb.2005.08.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-Src was the first proto-oncoprotein to be identified, and has become, the focus of many drug discovery programs. Src structures of a major inactive form have shown how the protein kinase is rigidified by several interdomain interactions; active configurations of Src are generated by release from this "assembled" or "bundled" form. Despite the importance of Src as a drug target, there is relatively little structural information available regarding the presumably more flexible active forms. Here we report three crystal structures of a dimeric active c-Src kinase domain, in an apo and two ligand complexed forms, with resolutions ranging from 2.9 angstrom to 1.95 angstrom. The structures show how the kinase domain, in the absence of the rigidifying interdomain interactions of the inactivation state, adopts a more open and flexible conformation. The ATP site inhibitor CGP77675 binds to the protein kinase with canonical hinge hydrogen bonds and also to the c-Src specific threonine 340. In contrast to purvalanol B binding in CDK2, purvalanol A binds in c-Src with a conformational change in a more open ATP pocket. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:222 / 231
页数:10
相关论文
共 49 条
[41]   Crystal structure of the Src family tyrosine kinase Hck [J].
Sicheri, F ;
Moarefi, I ;
Kuriyan, J .
NATURE, 1997, 385 (6617) :602-609
[42]   Cellular effects of purvalanol A: A specific inhibitor of cyclin-dependent kinase activities [J].
Villerbu, N ;
Gaben, AM ;
Redeuilh, G ;
Mester, J .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) :761-769
[43]   The 2.35 Å crystal structure of the inactivated form of chicken Src:: A dynamic molecule with multiple regulatory interactions [J].
Williams, JC ;
Weijland, A ;
Gonfloni, S ;
Thompson, A ;
Courtneidge, SA ;
Superti-Furga, G ;
Wierenga, RK .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 274 (05) :757-775
[44]   Three-dimensional structure of the tyrosine kinase c-Src [J].
Xu, WQ ;
Harrison, SC ;
Eck, MJ .
NATURE, 1997, 385 (6617) :595-602
[45]   Crystal structures of c-Src reveal features of its autoinhibitory mechanism [J].
Xu, WQ ;
Doshi, A ;
Lei, M ;
Eck, MJ ;
Harrison, SC .
MOLECULAR CELL, 1999, 3 (05) :629-638
[46]   Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation [J].
Yamaguchi, H ;
Hendrickson, WA .
NATURE, 1996, 384 (6608) :484-489
[47]   A renaissance for SRC [J].
Yeatman, TJ .
NATURE REVIEWS CANCER, 2004, 4 (06) :470-480
[48]   Dynamic coupling between the SH2 and SH3 domains of c-Src and hck underlies their inactivation by C-terminal tyrosine phosphorylation [J].
Young, MA ;
Gonfloni, S ;
Superti-Furga, G ;
Roux, B ;
Kuriyan, J .
CELL, 2001, 105 (01) :115-126
[49]   Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors [J].
Zhu, XT ;
Kim, JL ;
Newcomb, JR ;
Rose, PE ;
Stover, DR ;
Toledo, LM ;
Zhao, HL ;
Morgenstern, KA .
STRUCTURE, 1999, 7 (06) :651-661